Infrastructure Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,751
Closed -$211K 104
2023
Q2
$211K Buy
5,751
+284
+5% +$11.1K 0.02% 107
2023
Q1
$223K Buy
+5,467
New +$236K 0.03% 100
2021
Q4
Sell
-19,661
Closed -$855K 53
2021
Q3
$855K Buy
19,661
+6,260
+47% +$277K 0.13% 32
2021
Q2
$525K Sell
13,401
-5,100
-28% -$198K 0.1% 37
2021
Q1
$670K Buy
18,501
+9,980
+117% +$354K 0.19% 32
2020
Q4
$314K Buy
+8,521
New +$313K 0.1% 33

Other funds holding PFE

Infrastructure Capital Advisors's PFE Position: Q3 2023 in Review

Infrastructure Capital Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,751 shares — an estimated $211K sold.

Infrastructure Capital Advisors first reported a position in PFE in Q4 2020 and held it in 6 quarters. The position peaked at $855K in Q3 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Infrastructure Capital Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Infrastructure Capital Advisors sold 5,751 Pfizer shares in Q3 2023, an estimated $211K.
  • Infrastructure Capital Advisors first reported a position in Pfizer in Q4 2020 and held it in 6 quarters.
  • Infrastructure Capital Advisors's Pfizer position peaked at $855K in Q3 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Infrastructure Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.